Howard R. Yeaton

Overview

Howard R. Yeaton received an average of $289K in total compensation, including $264K in salary, at Akers Biosciences between 2019 and 2020.

Source: SEC filing on November 22, 2021.

Related executives

We found nine more executives who work or worked at Akers Biosciences.

Christopher Chapman

Akers Biosciences

Chief Medical Officer

Adam Kaplin

Akers Biosciences

Chief Scientific Officer

Paul Rivard

Akers Biosciences

Chief Legal Officer

Ian Rhodes

Akers Biosciences

Chief Financial Officer

Christopher Schreiber

Akers Biosciences

Chief Executive Officer

Raymond Akers

Akers Biosciences

Secretary

Thomas Nicolette

Akers Biosciences

Chief Executive Officer

Gary Rauch

Akers Biosciences

Vice President of Finance, Treasurer

News

You may also like